Anti-tumor effects of everolimus and metformin are complementary and glucose-dependent in breast cancer cells.

Ariaans, Gerke

Anti-tumor effects of everolimus and metformin are complementary and glucose-dependent in breast cancer cells. [electronic resource] - BMC cancer 03 2017 - 232 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1471-2407

10.1186/s12885-017-3230-8 doi


Antineoplastic Agents--pharmacology
Breast Neoplasms--metabolism
Cell Hypoxia
Cell Line, Tumor
Cell Survival--drug effects
Everolimus--pharmacology
Female
Glucose--metabolism
Glycolysis
Humans
Metformin--pharmacology